These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 406271)

  • 41. Prolactin-secreting pituitary adenomas in women. IV. Pituitary function in amenorrhea associated with normal or abnormal serum prolactin and sellar polytomography.
    Chang RJ; Keye WR; Monroe SE; Jaffe RB
    J Clin Endocrinol Metab; 1980 Oct; 51(4):830-5. PubMed ID: 6774995
    [No Abstract]   [Full Text] [Related]  

  • 42. Abnormal thyroid stimulating hormone following pituitary surgery.
    Worth GK; Retallack RW; Gutteridge DH
    J Endocrinol Invest; 1981; 4(2):233-6. PubMed ID: 7276463
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The pathophysiology of hyperprolactinemic states and the role of newer ergot compounds in their treatment.
    Frantz AG; Kleinberg DL
    Fed Proc; 1978 Jun; 37(8):2192-7. PubMed ID: 26606
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A rationale for the use of bromocriptine in patients with amenorrhea and normoprolactinemia.
    Corenblum B; Taylor PJ
    Fertil Steril; 1980 Sep; 34(3):239-41. PubMed ID: 6773822
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Treatment of hyperprolactinemic amenorrhea by pulsatile administration of gonadotropin-releasing hormone].
    Berg D; Rjosk HK; Jänicke F; von Werder K
    Geburtshilfe Frauenheilkd; 1983 Nov; 43(11):686-8. PubMed ID: 6360789
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased prolactin response to thyrotropin-releasing hormone in primary ovarian failure.
    Hochner-Celnikier D; Zylber-Haran E; Shilo S; Palti Z; Spitz IM
    Obstet Gynecol; 1982 Mar; 59(3):280-4. PubMed ID: 6804899
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of triiodothyronine treatment on prolactin secretion in patients with amenorrhea-galactorrhea.
    Aono T; Shioji T; Miyai K; Onishi T; Kurachi K
    J Clin Endocrinol Metab; 1977 Jan; 44(1):8-14. PubMed ID: 401825
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gonadotropin responses to gonadotropin-releasing hormone and prolactin responses to thyrotropin-releasing hormone and metoclopramide in women with amenorrhea and insulin-treated diabetes mellitus.
    Djursing H; Hagen C; Nyholm HC; Carstensen L; Andersen AN
    J Clin Endocrinol Metab; 1983 May; 56(5):1016-21. PubMed ID: 6403566
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [ Study of prolactin and blood gonadotropins in amenorrheas-galactorrhea. Dynamic exploation in 13 cases].
    Schaison G; Nathan C; L'Hermite M; Gilbert-Dreyfus
    Nouv Presse Med; 1975 Mar; 4(9):644-8. PubMed ID: 805417
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prolactinomas in women: current therapies.
    Robinson AG; Nelson PB
    Ann Intern Med; 1983 Jul; 99(1):115-8. PubMed ID: 6344716
    [No Abstract]   [Full Text] [Related]  

  • 51. [Treatment of hyperprolactinemic conditions with bromoergocryptine].
    Sas M; Godó G; Morvay J
    Zentralbl Gynakol; 1978; 100(22):1501-7. PubMed ID: 570784
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Antigonadotropic actions of prolactin. Study of 10 cases of women with hyperprolactinemia].
    Schaison G; Mowszowicz I; Cesselin E; Lagoguey M
    Nouv Presse Med; 1977 Feb; 6(6):425-8. PubMed ID: 320558
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impaired LH release following exogenous estrogen administration in patients with amenorrhea-galactorrhea syndrome.
    Aono T; Miyake A; Shioji T; Kinugasa T; Onishi T
    J Clin Endocrinol Metab; 1976 Apr; 42(4):696-702. PubMed ID: 177447
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Significance of hyperprolactinemia in 70 women with amenorrhea.
    Potashnik G; Bar-Ziv J; Glick S; Shoham A; Ben-Aderet N
    Isr J Med Sci; 1978 Jul; 14(7):753-61. PubMed ID: 681167
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Interference of prolactin in ovarian steroidogenesis in patients with hyperprolactinemic amenorrhea].
    Polatti F; Nava C; Zara C
    Minerva Ginecol; 1982; 34(1-2):1-6. PubMed ID: 7078820
    [No Abstract]   [Full Text] [Related]  

  • 56. Plasma growth hormone and prolactin response to thyrotropin releasing hormone, L-dopa and luteinizing hormone-releasing hormone in alcoholic patients with liver cirrhosis.
    Zanoboni A; Zanoboni-Muciaccia W; Bonfanti M; Gattei G; Zecca L
    Farmaco Prat; 1980 Sep; 35(9):455-65. PubMed ID: 6778710
    [No Abstract]   [Full Text] [Related]  

  • 57. Recovery from paradoxical growth hormone responses in acromegaly after transphenoidal selective adenomectomy.
    Hoyte KM; Martin JB
    J Clin Endocrinol Metab; 1975 Oct; 41(4):656-9. PubMed ID: 809457
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Prolactin].
    Lamberts SW; Klijn JG; Birkenhäger JC
    Ned Tijdschr Geneeskd; 1978 Sep; 122(36):1327-34. PubMed ID: 29235
    [No Abstract]   [Full Text] [Related]  

  • 59. [Hyperprolactinemia in relation to galactorrhea and amenorrhea].
    Zhang LZ
    Zhonghua Fu Chan Ke Za Zhi; 1983 Oct; 18(4):218-21. PubMed ID: 6426895
    [No Abstract]   [Full Text] [Related]  

  • 60. Thyrotrophin responses to intravenous thyrotrophin-releasing hormone in patients with hypothalamic and pituitary disease.
    McLaren EH; Hendricks S; Pimstone BL
    Clin Endocrinol (Oxf); 1974 Apr; 3(2):113-22. PubMed ID: 4366312
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.